Cumberland Pharmaceuticals Inc. Inventory, Gross
Cumberland Pharmaceuticals Inc. (CPIX) had Inventory, Gross of $14.61 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Inventory › Inventory, Gross
us-gaap:InventoryGross · last filed 2026-08-07
- 2026-06-30: Inventory, Gross $14.61M.
- 2026-03-31: Inventory, Gross $15.33M.
- 2025-12-31: Inventory, Gross $15.48M.
- 2025-09-30: Inventory, Gross $12.12M.
| Period end | Inventory, Gross | Inventory, Gross as first filed |
|---|---|---|
| 2026-06-30 | $14.61M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $15.33M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $15.48M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $12.12M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $12.75M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $14.04M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $15.01M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $16.34M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $16.17M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $17.24M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $17.41M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $16.97M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $17.62M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $17.71M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $17.39M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $18.14M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $19.79M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $20.47M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $17.48M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $19.74M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $19.98M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $20.43M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $22.29M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $22.73M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $23.27M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $23.72M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $24.43M 10-K · filed 2021-03-12 | $24.97M 10-K · filed 2020-03-20 |
| 2019-09-30 | $25.19M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $26.49M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $27.12M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $25.53M 8-K · filed 2020-12-10 | $27.83M 10-K · filed 2019-03-12 |
| 2017-12-31 | $6.74M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |